Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05453565 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis

Study acronym: FRESHLY
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 2024 to Nov 2026
    • Start date: Nov 2024 to Nov 2025
    • Study completion date: Nov 2025 to Nov 2026
    v4
  2. Start date: Jun 2023 to Nov 2024
    • Primary completion date: Jun 2024 to Nov 2024
    • Study completion date: Jun 2025 to Nov 2025
    v3
  3. Study description expanded, about 1 wordv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, individual patient data meta-analysis (IPDMA) of four multicentre, open-label, randomised clinical trials of initial haemodynamic resuscitation in patients with septic shock.
Trial Details
NCT Number NCT05453565
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Conditions
(from sponsor)		 Septic Shock, Fluid Resuscitation
Related terms Shock, Septic
Enrollment 7,838 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov